Journal of Integrative Medicine ›› 2017, Vol. 15 ›› Issue (5): 379-387.doi: 10.1016/S2095-4964(17)60349-2
Special Issue: Natural Drug
• Research Article • Previous Articles Next Articles
Lilian Uchoa Carneiroa,b, Ilna Gomes da Silvac, Mirian Eliza Alves de Souzaa,b, Wellington da Silva Côrtesa,b, Mário Geraldo de Carvalhoc, Bruno Guimarães Marinhoa,b
| 1 Ruíz SE, Morett AL.
2 Assis MCD, Zappi DC, Filardi FLR, Rodrigues RS.Growing knowledge: an overview of Seed Plant diversity in Brazil.
3 Santos DY, Salatino ML.Foliar flavonoid of Annonaceae from Brazil: taxonomic significance.
4 Waldhoer M, Bartlett SE, Whistler JL.Opioid receptors.
5 Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dollé P, Tzavara E, Hanoune J, Roques BP, Kieffer BL.Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor gene.
6 Contet C, Kieffer BL, Befort K.Mu opioid receptor: a gateway to drug addiction.
7 Stein C, Machelska H.Modulation of peripheral sensory neurons by the immune system: implications for pain therapy.
8 Labuz D, Machelska H.Stronger antinociceptive efficacy of opioids at the injured nerve trunk than at its peripheral terminals in neuropathic pain.
9 Williams JT, Ingram SL, Henderson G, Chavkin C, Von Zastrow M, Schulz S, Koch T, Evans CJ, Christie MJ.Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.
10 Baron R, Binder A, Wasner G.Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment.
11 Sakuraba A, Sato T, Kamada N, Kitazume M, Sugita A, Hibi T.Th1/Th17 immune response is induced by mesenteric lymphnode dendritic cells in Crohn’s disease.
12 Sato T, Kanai T, Watanabe M, Sakuraba A, Okamoto S, Nakai T.Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease.
13 Liao W, Lin JX, Leonard WJ.IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation.
14 Dos Santos GC, Fernandes RD, Barros TR, Abreu HS, Suzart LR, de Carvalho MG, Braz-Filho R, Marinho BG. Antinociceptive and anti-inflammatory activities of the methanolic extract from the stem bark of
15 Leitão SG, dos Santos TC, Monache FD, Matheus ME, Fernandes PD, Marinho BG. Phytochemical profile and analgesic evaluation of
16 Li Y, Zheng B, Tian H, Xu X, Sun Y, Mei Q, Lin X, Liu L.Yupingfeng powder relieves the immune suppression induced by dexamethasone in mice.
17 Otuki MF, Ferreira J, Lima FV, Meyre-Silva C, Malheiros A, Muller LA, Cani GS, Santos AR, Yunes RA, Calixto JB.Antinociceptive properties of mixture of α-amyrin and β-amyrin triterpenes: evidence for participation of protein kinase C and protein kinase A pathways.
18 Tabarelli Z, Berlese DB, Sauzem PD, Rubin MA, Missio TP, Teixeira MV, Sinhorin AP, Martins MAP, Zanatta N, Bonacorso HG, Mello CF.Antinociceptive effect of novel pyrazolines in mice.
19 19 Gonçalves GM, Capim SL, Vasconcellos MLAA, Marinho BG. Antihyperalgesic effect of [(±)-(2,4,6-cis)-4-chloro- 6-(naphthalen-1-yl)-tetrahydro-2H-pyran-2-yl]methanol: participation of the NO/cGMP/KATP pathway and κ-opioid receptor.
20 Koster R, Anderson M, De Beer EJ.Acetic acid for analgesic screening.
21 D’Amour FE, Smith DL. A method for determining loss of pain sensation.
22 Erdos EG.
23 Vigil SV, De Liz R, Medeiros YS, Fröde TS.Efficacy of tacrolimus in inhibiting inflammation caused by carrageenan in a murine model of air pouch.
24 Barros HM, Tannhauser MA, Tannhauser SL, Tannhauser M.Enhanced detection of hyperactivity after drug withdrawal with a simple modification of the open-field apparatus.
25 Block LC, Santos ARS, De Souza MM, Scheidt C, Yunes RA, Santos MA, Delle Monache F, Filho VC.Chemical and pharmacological examination of antinociceptive constituents of
26 Nguelefack TB, Fotio AL, Watcho P, Wansi SL, Dimo T, Kamanyi A.Analgesic properties of the aqueous and ethanol extract of the leaves ofKalanchoe crenata (Crassulaceae).
27 Oliveira SM, Gewehr C, Dalmolin GD, Cechinel CA, Wentz A, Lourega RV, Sehnem RC, Zanatta N, Martins MA, Rubin MA, Bonacorso HG, Ferreira J.Antinociceptive effect of a novel tosylpyrazole compound in mice.
28 Yi T, Zhao ZZ, Yu ZL, Chen HB.Comparison of the antiinflammatory and anti-nociceptive effects of three medicinal plants known as “Snow Lotus” herb in traditional Uighur and Tibetan medicines.
29 Pinheiro MM, Miltojevic AB, Radulovic NS, Abdul-Wahab IR, Boylan F, Fernandes PD.Anti-inflammatory activity of Choisya ternate Kunth essential oil, ternanthranin, and its two synthetic analogs (methyl and propyl N-methylanthranilates).
30 Milano J, Oliveira SM, Rossato MF, Sauzem PD, Machado P, Beck P, Zanatta N, Martins MA, Mello CF, Rubin MA, Ferreira J, Bonacorso HG.Antinociceptive effect of novel trihalomethyl-substituted pyrazoline methyl esters in formalina and hot-plate tests in mice.
31 Zhang L, Hu JJ, Lin JW, Fang WS, Du GH.Antiinflammatory and analgesic effects of ethanol and aqueous extracts ofPterocephalus hookeri (C.B. Clarke) Höeck.
32 Yi T, Lo H, Zhao Z, Yu Z, Yang Z, Chen H.Comparison of the chemical composition and pharmacological effects of the aqueous and ethanolic extracts from a Tibetan “Snow Lotus” (
33 Janssen PA, Niemegeers CJ, Dony JG.The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water-induced tail withdrawal reflex in rats.
34 Vale TG, Matos FJA, de-Lima TCM, Viana GSB. Behavioural effects of essential oils fromLippia alba (Mill) N.E Brown chemotypes.
35 Silva J, Abebe W, Sonsa SM, Duarte VG, Machado ML, Matos FJA.Analgesic and antiinflammatory effects of essential oil of
36 Hill RG.The status of naloxone in the identification of pain control mechanisms operated by endogenous opioids.
37 37 Smith JS, Zubieta JK, Price JC, Flesher JE, Madar I, Lever JR, Kinter CM, Dannals RF, Frost JJ. Quantification of δ-opioid receptors in human brain with N1′-([11C] methyl) naltrindole and positron emission tomography.
38 Peng J, Sarkar S, Chang SL.Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR.
39 Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F, Befort K, Gavériaux-Ruff C, Dierich A, LeMeur M, Valverde O, Maldonado R, Kieffer BL. Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses.
40 Gaveriaux-Ruff C, Nozaki C, Nadal X, Hever XC, Weibel R, Matifas A, Reiss D, Filliol D, Nassar MA, Wood JN, Maldonado R, Kieffer BL.Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia.
41 Pradhan AA, Befort K, Nozaki C, Gaveriaux-Ruff C, Kieffer BL.The delta opioid receptor: an evolving target for the treatment of brain disorders.
42 Gaveriaux-Ruff C, Kieffer BL.Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.
43 Costa G, Ferreira JP, Vitorino C, Pina ME, Sousa JJ, Figueiredo IV, Batista MT.Polyphenols from
44 Sadeghi H, Hajhashemi V, Minaiyan M, Movahedian A, Talebi A.Further studies on anti-inflammatory activity of maprotiline in carrageenan-induced paw edema in rat.
45 Sekut L, Junior Menius JA, Brackeen MF, Connolly KM.Evaluation of the significance of elevated levels of systemic and localized tumor necrosis factor in different animal models of inflammation.
46 Dinarello CA.Proinflammatory cytokines.
47 Woolf CJ.What is this thing called pain?
48 Alessandri AL, Sousa LP, Lucas CD, Rossi AG, Pinho V, Teixeira MM.Resolution of inflammation: mechanisms and opportunity for drug development.
49 Schein CH.The shape of the messenger: using protein structure information to design novel cytokine-based therapeutics.
50 Ebnet K, Vestweber D.Molecular mechanisms that control leukocyte extravasation: the selections and the chemokines.
51 Dinarello CA.The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1.
|No related articles found!|